Preimplantation Diagnosis
Authors:
- 15 November 2016
- book chapter
- Published by Wiley
- p. 1-21
Abstract
Preimplantation diagnosis is testing for a causative gene before pregnancy, allowing the preselection of unaffected embryos before implantation into the uterus. It has currently become an alternative to prenatal diagnosis, providing an option for at‐risk couples to have unaffected children of their own without facing the risk of a pregnancy termination after prenatal diagnosis. Preimplantation diagnosis is also extended to late‐onset common disorders with genetic predisposition, such as cancer and heart disease, for which no preclinical diagnosis and effective preventive management exists. The other nontraditional application of preimplantation diagnosis is preimplantation HLA (human leukocyte antigen) typing to improve the access to the HLA‐identical stem cell transplantation, and this will contribute to the development of the cellular therapy for genetic and acquired disorders. However, the major current application of preimplantation genetic testing is detection and avoidance of aneuploid embryos, based on the currently used next‐generation technologies for 24‐chromosome aneuploidy testing, as the practical means in assisted reproduction technology (ART) to improve the in vitro fertilisation (IVF) effectiveness and general standards of ART. Key Concepts: PGD is no longer a research tool, but the established procedure in the genetic practices and ART. PGD not only avoids the birth of affected offspring but, most importantly, also ensures an unaffected pregnancy from the onset. Indications for PGD have currently been extended from the traditional ones, which are similar to prenatal diagnosis, to those that are not acceptable for prenatal diagnosis, such as late‐onset common disorders or identification of HLA match for stem cell transplantation. The majority of PGD is still performed for aneuploidy testing, as a tool to improve the efficiency of IVF. One of the most recent changes in PGD procedure in the last few years is shifting from blastomere biopsy to blastocyst sampling and vitrification, followed by the frozen transfer of tested embryos. The other important development in PGD is a shift of genetic testing from FISH testing for a few chromosomes most commonly involved in trisomies to the next‐generation technologies for 24‐chromosome aneuploidy testing. The number of different genetic conditions tested by PGD at the present time is over 400 and can be done not only for inherited conditions but also for those determined by de novo mutations. PGD for single‐gene disorders became extremely accurate and reliable, with as high as 99.5% accuracy in our PGD experience, which is the world's largest PGD series. The shift of PGD for aneuploidies from FISH to NGS‐based testing has further improved the pregnancy and implantation rates, leading also to a considerable reduction of spontaneous abortions. PGD is already moving towards the universal approaches, combining the testing for single‐gene and chromosomal disorders in a single test.Keywords
This publication has 24 references indexed in Scilit:
- Improving assisted reproductive technology pregnancy rates: excluding aneuploid and interrogating euploid embryosFertility and Sterility, 2015
- First systematic experience of preimplantation genetic diagnosis for single-gene disorders, and/or preimplantation human leukocyte antigen typing, combined with 24-chromosome aneuploidy testingFertility and Sterility, 2015
- Preimplantation HLA typing for stem cell transplantation treatment of hemoglobinopathiesThalassemia Reports, 2014
- Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trialFertility and Sterility, 2013
- PGD for inherited cardiac diseasesReproductive BioMedicine Online, 2012
- Seven years of experience of preimplantation HLA typing: a clinical overview of 327 cyclesReproductive BioMedicine Online, 2011
- Polar body-based preimplantation genetic diagnosis for Mendelian disordersMolecular Human Reproduction, 2011
- Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypesJournal of Medical Genetics, 2009
- Guidelines for good practice in PGD: programme requirements and laboratory quality assuranceReproductive BioMedicine Online, 2008
- Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplificationNature, 1990